If I Could Only Buy 1 Space Stock for the Next Decade, It Wouldn't Be SpaceX or Rocket Lab

Planet Labs reported 58% year-over-year quarterly revenue growth to $116 million, an $815 million backlog, 57% gross margin, and positive year-to-date free cash flow, supported by expanding government satellite-imagery contracts. The company forecasts fiscal-year revenue above $441 million and trades at a 14.6x price-to-sales ratio, versus cited multiples of 96x for SpaceX and 55x for Rocket Lab. The article argues Planet Labs offers comparatively attractive long-term space-economy exposure, though execution risk remains around sustaining growth and reaching operating-margin scale.

Analysis

PL’s differentiation is not simply lower valuation: its archive can become a data moat if customers embed its imagery and change-detection tools into operational workflows. That creates higher renewal probability and potentially software-like incremental economics, whereas launch businesses must repeatedly fund hardware, manufacturing capacity, and mission execution. The key 6-18 month equity catalyst is evidence that government awards convert into recognized revenue without a corresponding step-up in constellation-replacement capex.

The near-term risk is that investors extrapolate contract headline values into annual revenue too quickly. Government imagery programs can have long procurement, security-clearance, and task-order cycles; backlog quality matters more than aggregate backlog, specifically funded versus unfunded awards, duration, termination provisions, and the share tied to low-margin pass-through services. Positive free cash flow also needs scrutiny: sustained FCF after satellite replenishment, rather than a temporary working-capital benefit, is the relevant proof point for multiple expansion.

A relative-value expression is more attractive than an outright sector bet. RKLB retains legitimate upside from defense awards, launch cadence, and Neutron execution, but its valuation is more exposed to any schedule slip or capital-spending reset. Conversely, PL’s multiple can compress sharply if quarterly growth falls below the level needed to demonstrate operating leverage; a weaker-than-expected federal budget environment or delayed European procurement would invalidate the long thesis.

Consensus may be underestimating the second-order beneficiary of geopolitical demand: analytics vendors and defense integrators that turn imagery into actionable intelligence can capture more value than raw-image providers. PL must show that AI products lift ARPU and retention rather than commoditize image collection. Watch quarterly net retention, remaining performance obligations, capex-to-revenue, and adjusted operating-margin progression rather than relying on promotional comparisons to private-market SpaceX valuations.

Key Decisions for Investors

• Initiate a 3-6 month market-neutral pair: long PL / short RKLB, sized dollar-neutral and rebalanced after earnings. Target a 15-20% relative return if PL sustains >30% growth with improving operating margin while RKLB faces valuation sensitivity; exit if PL growth drops below 20% or RKLB materially de-risks Neutron timing with funded customer commitments.
• For a directional PL position, wait for the next earnings release or a confirmed government award conversion into revenue guidance before building a full position. Add only if management demonstrates positive free cash flow after recurring satellite capex; cap downside at a 15% position-level loss because contract timing can produce volatile quarters.
• Avoid shorting SpaceX/SPCX as presented: it is not a standard publicly tradable equity and private-market valuation comparisons are not a clean hedge. Use RKLB or the ARKX ETF only as imperfect public-space exposure proxies.
• Set an earnings watch item for PL: any cut to full-year revenue outlook, deterioration in gross margin below the mid-50% range, or a material rise in capex would challenge the software-like economics thesis and warrant closing the long leg.